Related Experiment Video
Updated: Jun 6, 2026
04:25
Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models
Published on: October 28, 2021
Gliosarcoma: a study of four cases
Yildiz Güney1, Ayse Hiçsönmez, Sercan Yilmaz
1Department of Radiation Oncology, Faculty of Medicine, Ankara University, Turkey.
Rare Tumors
|December 9, 2010
Summary
Gliosarcomas (GS) are rare, aggressive central nervous system tumors with a poor prognosis. A multidisciplinary treatment approach may offer slightly extended survival times for patients with these challenging brain tumors.
Area of Science:
- Neuro-oncology
- Central Nervous System (CNS) Tumors
- Neurosurgery
Background:
- Gliosarcomas (GS) represent a rare and highly malignant subtype of primary brain tumors.
- These tumors are characterized by aggressive behavior and a generally poor patient prognosis.
Observation:
- This report details the clinical course and outcomes of four patients diagnosed with gliosarcoma.
- The median survival observed in this cohort was 9.25 months.
Findings:
- The prognosis for gliosarcoma patients remains unfavorable despite current treatment modalities.
- A combination of surgery, radiation therapy, and chemotherapy (multidisciplinary approach) was associated with a modest improvement in survival.
Implications:
- Further research is warranted to improve therapeutic strategies for gliosarcoma.
- Optimizing multidisciplinary care may enhance outcomes for patients with these rare CNS malignancies.
